United Therapeutics (UTHR) Revenue (QoQ) (2009 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) Revenue (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.23% |
| Mar 31, 2026 | -1.10% |
| Dec 31, 2025 | -1.16% |
| Sep 30, 2025 | 0.11% |
| Jun 30, 2025 | 0.53% |
| Mar 31, 2025 | 7.95% |
| Dec 31, 2024 | -1.74% |
| Sep 30, 2024 | 4.76% |
| Jun 30, 2024 | 5.49% |
| Mar 31, 2024 | 10.25% |
| Dec 31, 2023 | 0.87% |
| Sep 30, 2023 | 2.16% |
| Jun 30, 2023 | 17.68% |
| Mar 31, 2023 | 3.13% |
| Dec 31, 2022 | -4.75% |
| Sep 30, 2022 | 10.52% |
| Jun 30, 2022 | 1.08% |
| Mar 31, 2022 | 11.25% |
| Dec 31, 2021 | -6.63% |
| Sep 30, 2021 | -0.40% |